KDL medical directors worked with OHSU researchers and oncologists to determine that targeted sequencing and IHC can identify clinically informative molecular abnormalities in CRPC

Molecular Testing in Patients With Castration-Resistant Prostate Cancer and Its Impact on Clinical Decision Making